SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2jii'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FBM_B_RTLB951_0
(PROTEIN (CARTILAGE
OLIGOMERIC MATRIX
PROTEIN))
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 4 THR A 173
LEU A 180
LEU A 257
GLN A 215
None
1.26A 1fbmA-2jiiA:
undetectable
1fbmA-2jiiA:
8.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1H9Z_A_RWFA3001_1
(SERUM ALBUMIN)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 11 ALA A 240
LEU A 324
LEU A 290
LEU A 376
ALA A 309
None
1.14A 1h9zA-2jiiA:
undetectable
1h9zA-2jiiA:
20.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_A_SAMA2201_1
(PROTEIN (METHIONINE
REPRESSOR))
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 4 HIS A 304
ALA A 330
PHE A 331
GLY A 305
None
1.39A 1mj2B-2jiiA:
undetectable
1mj2B-2jiiA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJ2_C_SAMC1200_1
(PROTEIN (METHIONINE
REPRESSOR))
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 4 HIS A 304
ALA A 330
PHE A 331
GLY A 305
None
1.37A 1mj2D-2jiiA:
undetectable
1mj2D-2jiiA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_B_SAMB200_0
(METHIONINE REPRESSOR)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 4 HIS A 304
ALA A 330
PHE A 331
GLY A 305
None
1.42A 1mjoA-2jiiA:
undetectable
1mjoA-2jiiA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MJO_D_SAMD200_1
(METHIONINE REPRESSOR)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 4 HIS A 304
ALA A 330
PHE A 331
GLY A 305
None
1.38A 1mjoD-2jiiA:
undetectable
1mjoD-2jiiA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P93_D_DEXD4999_2
(GLUCOCORTICOID
RECEPTOR)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 LEU A 211
MET A 145
LEU A 149
GLN A 177
None
1.27A 1p93D-2jiiA:
undetectable
1p93D-2jiiA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SV5_A_65BA600_0
(REVERSE
TRANSCRIPTASE)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 10 LEU A 381
LYS A 382
VAL A 283
LEU A 428
TYR A 385
None
1.47A 1sv5A-2jiiA:
undetectable
1sv5A-2jiiA:
21.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_B_9CRB600_2
(RETINOIC ACID
RECEPTOR, BETA)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
3 / 3 LEU A 262
PHE A 313
ARG A 174
None
0.88A 1xdkB-2jiiA:
undetectable
1xdkB-2jiiA:
22.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2YGN_A_PCFA1179_1
(WNT INHIBITORY
FACTOR 1)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 ILE A 422
PRO A 389
VAL A 314
PHE A 356
None
1.27A 2ygnA-2jiiA:
undetectable
2ygnA-2jiiA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_C_2FAC500_1
(ADENOSYLHOMOCYSTEINA
SE)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 12 HIS A 304
GLU A 214
LYS A 203
LEU A 324
PHE A 218
None
1.34A 2zj0C-2jiiA:
undetectable
2zj0C-2jiiA:
19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ZJ0_D_2FAD500_1
(ADENOSYLHOMOCYSTEINA
SE)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 12 HIS A 304
GLU A 214
LYS A 203
LEU A 324
PHE A 218
None
1.37A 2zj0D-2jiiA:
undetectable
2zj0D-2jiiA:
19.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DL9_A_V2HA602_1
(CYTOCHROME P450 2R1)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 ASN A 213
ALA A 222
LEU A 259
THR A 308
None
0.97A 3dl9A-2jiiA:
undetectable
3dl9A-2jiiA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E22_B_LOCB700_2
(TUBULIN BETA-2B
CHAIN)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
6 / 11 LEU A 324
LEU A 239
ALA A 293
LEU A 297
ASN A 300
ALA A 222
None
1.28A 3e22B-2jiiA:
undetectable
3e22B-2jiiA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E22_D_LOCD700_2
(TUBULIN BETA-2B
CHAIN)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
6 / 11 LEU A 324
LEU A 239
ALA A 293
LEU A 297
ASN A 300
ALA A 222
None
1.33A 3e22D-2jiiA:
undetectable
3e22D-2jiiA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FBX_A_ACTA608_0
(PUTATIVE
PHOSPHOLIPASE B-LIKE
2)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
3 / 3 GLU A 344
VAL A 343
CYH A 365
None
1.07A 3fbxA-2jiiA:
undetectable
3fbxA-2jiiA:
21.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FSU_A_C2FA995_0
(5,10-METHYLENETETRAH
YDROFOLATE REDUCTASE)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 12 GLN A 285
LEU A 470
SER A 273
GLN A 267
LEU A 278
None
1.32A 3fsuA-2jiiA:
undetectable
3fsuA-2jiiA:
20.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ONN_A_ACTA270_0
(PROTEIN SSM1)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 LEU A 278
SER A 282
LEU A 470
PRO A 471
None
1.30A 3onnA-2jiiA:
undetectable
3onnA-2jiiA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4B3O_A_EFZA1557_1
(REVERSE
TRANSCRIPTASE/RIBONU
CLEASE H)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 9 LEU A 381
LYS A 382
VAL A 283
LEU A 428
TYR A 385
None
1.47A 4b3oA-2jiiA:
undetectable
4b3oA-2jiiA:
20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DAJ_B_0HKB2000_2
(MUSCARINIC
ACETYLCHOLINE
RECEPTOR M3,
LYSOZYME)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
3 / 3 ASN A 311
LEU A 294
PHE A 356
None
0.70A 4dajB-2jiiA:
undetectable
4dajB-2jiiA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4EJG_C_NCTC501_1
(CYTOCHROME P450 2A13)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 7 PHE A 217
PHE A 218
LEU A 262
LEU A 259
None
0.81A 4ejgC-2jiiA:
undetectable
4ejgC-2jiiA:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODR_A_FK5A201_1
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD,
PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP1A CHIMERA)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 12 LEU A 376
LEU A 384
LEU A 284
LEU A 453
ILE A 312
None
0.94A 4odrA-2jiiA:
undetectable
4odrB-2jiiA:
undetectable
4odrA-2jiiA:
14.41
4odrB-2jiiA:
14.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WEV_X_SUZX402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER B10)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 10 HIS A 304
ARG A 289
TRP A 383
CYH A 379
LEU A 376
None
1.37A 4wevX-2jiiA:
0.0
4wevX-2jiiA:
21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNU_A_QDNA602_1
(CYTOCHROME P450 2D6)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 11 LEU A 290
PHE A 296
GLY A 326
ALA A 240
PHE A 217
None
1.17A 4wnuA-2jiiA:
undetectable
4wnuA-2jiiA:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNU_C_QDNC602_1
(CYTOCHROME P450 2D6)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 11 LEU A 290
PHE A 296
GLY A 326
ALA A 240
PHE A 217
None
1.28A 4wnuC-2jiiA:
undetectable
4wnuC-2jiiA:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5W97_J_CHDJ101_1
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 146
LEU A 149
None
1.32A 5w97J-2jiiA:
undetectable
5w97J-2jiiA:
11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1B_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 146
LEU A 149
None
1.42A 5x1bJ-2jiiA:
undetectable
5x1bJ-2jiiA:
11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1B_J_CHDJ101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 147
LEU A 149
None
1.35A 5x1bJ-2jiiA:
undetectable
5x1bJ-2jiiA:
11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X1F_W_CHDW101_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 147
LEU A 149
None
1.29A 5x1fW-2jiiA:
undetectable
5x1fW-2jiiA:
11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIW_D_LOCD503_2
(TUBULIN BETA CHAIN)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 12 LEU A 324
LEU A 239
ALA A 293
LEU A 297
ASN A 300
None
1.31A 5xiwD-2jiiA:
undetectable
5xiwD-2jiiA:
13.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Y2T_B_8LXB501_0
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
5 / 12 LEU A 388
PHE A 407
TYR A 446
LEU A 449
HIS A 298
None
EDO  A1474 ( 4.8A)
None
EDO  A1473 (-4.4A)
None
1.10A 5y2tB-2jiiA:
undetectable
5y2tB-2jiiA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6G31_A_ZOLA401_0
(GERANYLGERANYL
PYROPHOSPHATE
SYNTHASE)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 7 ASP A 360
GLN A 374
GLN A 405
LYS A 363
None
1.20A 6g31A-2jiiA:
undetectable
6g31A-2jiiA:
12.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6HU9_S_PCFS603_0
(CYTOCHROME B-C1
COMPLEX SUBUNIT 8
CYTOCHROME C OXIDASE
POLYPEPTIDE 5A,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 7 GLY A 263
PHE A 313
VAL A 322
SER A 268
None
0.93A 6hu9S-2jiiA:
undetectable
6hu9q-2jiiA:
0.2
6hu9S-2jiiA:
12.54
6hu9q-2jiiA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_J_CHDJ102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 146
LEU A 149
None
1.31A 6nknJ-2jiiA:
undetectable
6nknJ-2jiiA:
11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_J_CHDJ102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 147
LEU A 149
None
1.30A 6nknJ-2jiiA:
undetectable
6nknJ-2jiiA:
11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_W_CHDW102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 146
LEU A 149
None
1.34A 6nknW-2jiiA:
undetectable
6nknW-2jiiA:
11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6NKN_W_CHDW102_0
(CYTOCHROME C OXIDASE
SUBUNIT 7A1,
MITOCHONDRIAL)
2jii SERINE/THREONINE-PRO
TEIN KINASE VRK3
MOLECULE: VACCINIA
RELATED KINASE 3

(Homo
sapiens)
4 / 5 TYR A 141
MET A 145
THR A 147
LEU A 149
None
1.34A 6nknW-2jiiA:
undetectable
6nknW-2jiiA:
11.69